Delivery Order SPE2DB20D3303-SPE2DB24FZ6B3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,992.38, is for the delivery of Lamotrigine ER 300 mg Tablets in 30-count packages. This is a firm fixed price delivery order contract with an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $2,990.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for Lamotrigine ER 50 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD9DE, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,872.07 firm fixed-price delivery order is for the supply of 30-count packages of the prescription drug Lamotrigine ER 50 mg tablets. This contract has no set-aside designation and is scheduled for completion by September 3, 2024. Amerisourcebergen holds several Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,926.19 firm fixed-price delivery order is for LAMOTRIGINE ER 250 MG TABLET 30S, a generic medication. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $50,133.85 for the supply of pharmaceutical products and medical supplies to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has no set-aside designation and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,931.44 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical and medical products to DLA facilities supporting the Department of Defense. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through 2025, as well as a...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order contract valued at $29,760.10 for the provision of pharmaceutical and medical supplies. This Firm Fixed Price contract has an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a comprehensive range of pharmaceutical...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $16,500.24, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This award is not set aside and is a firm fixed price...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceutical products and medical supplies. The $2,457.54 firm fixed-price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen has a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of medications...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,203.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ6B3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,111.01 firm fixed-price delivery order is for the supply of 4,564,449,522 lamotrigine orally disintegrating tablets (100 mg, 30 count) with a completion date of May 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 4/30/24 |